Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamran Hosseini

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Ophthalmology and Therapy|August 19, 2017
Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 StudyWilliam Trattler, Kamran Hosseini
Journal of Ophthalmic & Vision Research|March 29, 2012
Combination therapies in ophthalmology: implications for intravitreal deliveryGholam A Peyman, Kamran Hosseini
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|January 19, 2012
A minimally invasive jet injector for intravitreal and subconjunctival injectionGholam A Peyman, Kamran Hosseini, Michel Cormier
Clinical Ophthalmology (Auckland, N.Z.)|November 20, 2013
A Phase III clinical study to evaluate the efficacy of combined azithromycin and dexamethasone in the treatment of blepharoconjunctivitisKamran Hosseini, Judith Hutcheson, Richard L Lindstrom
Biophysical Journal|May 22, 2021
EMT changes actin cortex rheology in a cell-cycle-dependent mannerKamran Hosseini, Annika Frenzel, Elisabeth Fischer-Friedrich
Physical Biology|August 31, 2023
EMT induces characteristic changes of Rho GTPases and downstream effectors with a mitosis-specific twistKamran Hosseini, Annika Frenzel, Elisabeth Fischer-Friedrich
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 22, 2011
Pharmacokinetic comparisons of bromfenac in DuraSite and XibromErwin C Si, Lyle M Bowman, Kamran Hosseini
Health and Quality of Life Outcomes|January 13, 2018
Development and evaluation of a measure of patient-reported symptoms of BlepharitisKamran Hosseini, Linda B Bourque, Ron D Hays
IET Nanobiotechnology|April 6, 2023
Synthesis of Zeolitic imidazolate frameworks-8@ layered double hydroxide polyhedral nanocomposite with designed porous voids as an effective carrier for anti-cancer drug-controlled deliveryAzita Dilmaghani, Kamran Hosseini, Vahideh Tarhriz, et al.
Non-Coding RNA Research|June 9, 2025
CircRNA-based AntimiR therapy: A novel approach to hypertension treatmentVahideh Tarhriz, Kamran Hosseini, Leila Abkhooie, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Ophthalmology and Therapy|August 19, 2017
Twice-Daily vs. Once-Daily Dosing with 0.075% Bromfenac in DuraSite: Outcomes from a 14-Day Phase 2 StudyWilliam Trattler, Kamran Hosseini
Journal of Ophthalmic & Vision Research|March 29, 2012
Combination therapies in ophthalmology: implications for intravitreal deliveryGholam A Peyman, Kamran Hosseini
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|January 19, 2012
A minimally invasive jet injector for intravitreal and subconjunctival injectionGholam A Peyman, Kamran Hosseini, Michel Cormier
Clinical Ophthalmology (Auckland, N.Z.)|November 20, 2013
A Phase III clinical study to evaluate the efficacy of combined azithromycin and dexamethasone in the treatment of blepharoconjunctivitisKamran Hosseini, Judith Hutcheson, Richard L Lindstrom
Biophysical Journal|May 22, 2021
EMT changes actin cortex rheology in a cell-cycle-dependent mannerKamran Hosseini, Annika Frenzel, Elisabeth Fischer-Friedrich
Physical Biology|August 31, 2023
EMT induces characteristic changes of Rho GTPases and downstream effectors with a mitosis-specific twistKamran Hosseini, Annika Frenzel, Elisabeth Fischer-Friedrich
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 22, 2011
Pharmacokinetic comparisons of bromfenac in DuraSite and XibromErwin C Si, Lyle M Bowman, Kamran Hosseini
Health and Quality of Life Outcomes|January 13, 2018
Development and evaluation of a measure of patient-reported symptoms of BlepharitisKamran Hosseini, Linda B Bourque, Ron D Hays
IET Nanobiotechnology|April 6, 2023
Synthesis of Zeolitic imidazolate frameworks-8@ layered double hydroxide polyhedral nanocomposite with designed porous voids as an effective carrier for anti-cancer drug-controlled deliveryAzita Dilmaghani, Kamran Hosseini, Vahideh Tarhriz, et al.
Non-Coding RNA Research|June 9, 2025
CircRNA-based AntimiR therapy: A novel approach to hypertension treatmentVahideh Tarhriz, Kamran Hosseini, Leila Abkhooie, et al.
Pageof 6